{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T06:12:50Z","timestamp":1778825570686,"version":"3.51.4"},"reference-count":142,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2026,5,4]]},"DOI":"10.1080\/17512433.2026.2667340","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:52:23Z","timestamp":1777474343000},"page":"457-470","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Developing treatment strategies to optimize outcomes in patients with psoriatic arthritis"],"prefix":"10.1080","volume":"19","author":[{"given":"Fadi","family":"Kharouf","sequence":"first","affiliation":[{"name":"Hebrew University of Jerusalem","place":["Jerusalem, Israel"]},{"name":"University of Toronto","place":["Toronto, Canada"]},{"name":"University Health Network","place":["Toronto, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiman","family":"Arraf","sequence":"additional","affiliation":[{"name":"Rambam Medical Center","place":["Haifa, Israel"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod","family":"Chandran","sequence":"additional","affiliation":[{"name":"University of Toronto","place":["Toronto, Canada"]},{"name":"University Health Network","place":["Toronto, Canada"]},{"name":"University of Toronto","place":["Toronto, Canada"]},{"name":"University of Toronto","place":["Toronto, Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2026,5,3]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081860"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-021-00293-y"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1505557"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-020-04775-2"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25513"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.130797"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2025.152701"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2004.033928"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00798-0"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217159"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2024.2384705"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2014.905741"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.102053"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20162"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.01.012"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2024-1250"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2026.03.011"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00347-5"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204858"},{"issue":"5","key":"e_1_3_5_22_1","first-page":"1045","article-title":"Remission in psoriatic arthritis","volume":"28","author":"Gladman DD","year":"2001","unstructured":"Gladman DD, Hing EN, Schentag CT, et al. Remission in psoriatic arthritis. J Rheumatol. 2001;28(5):1045\u20131048.","journal-title":"J Rheumatol"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12607"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003339"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2024-1162"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22576"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22529"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2025-0314.POD08"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02417-x"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2025.152859"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24593"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-220562"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2025.2601050"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30830-4"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054901"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.689"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7046"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2015.10.019"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2021.101694"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2817"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kes242"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00368"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-020-00215-6"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21711"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-016-1194-8"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kew326"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf282"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2024-1148"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keag132"},{"issue":"9","key":"e_1_3_5_50_1","article-title":"Understanding the impact of overweight and obesity on treatment response in psoriatic arthritis: results from a longitudinal cohort study [abstract]","volume":"77","author":"Mehta P","year":"2025","unstructured":"Mehta P, Yang M, Carrizo Abarza V, et al. Understanding the impact of overweight and obesity on treatment response in psoriatic arthritis: results from a longitudinal cohort study [abstract]. Arthritis Rheumatol. 2025;77(suppl 9). https:\/\/acrabstracts.org\/abstract\/understanding-the-impact-of-overweight-and-obesity-on-treatment-response-in-psoriatic-arthritis-results-from-a-longitudinal-cohort-study\/","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"e_1_3_5_51_1","first-page":"S36","article-title":"The enthesis in psoriatic arthritis","volume":"33","author":"McGonagle D","year":"2015","unstructured":"McGonagle D, Tan AL. The enthesis in psoriatic arthritis. Clin Exp Rheumatol. 2015;33(5 Suppl 93):S36\u201339.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.12.008"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-0298-6_4"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120233"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203643"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.2174\/0115733971339350240830104424"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151376"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207963"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-205056"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2023-0716"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2024-004636"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.3390\/geriatrics5040085"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1111\/ced.12850"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.05.388"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.05.117"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2021-eular.1002"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2022.08.061"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2024.2701"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.05.023"},{"key":"e_1_3_5_70_1","unstructured":"Takeda. A multi-center randomized double-blind placebo- and active-controlled phase 3 study to evaluate the efficacy and safety of zasocitinib (TAK-279) in subjects with active psoriatic arthritis who are Na\u00efve to biologic disease-modifying antirheumatic drugs (LATITUDE-PsA-3001) [Internet]. Report No.: nCT06671483. Available from clinicaltrials.gov; 2025 [cited 2025 Sep 22]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06671483"},{"key":"e_1_3_5_71_1","unstructured":"Takeda. A multi-center randomized double-blind and placebo-controlled phase 3 study to evaluate the efficacy and safety of zasocitinib (TAK-279) in subjects with active psoriatic arthritis stratified by prior biologic use (LATITUDE-PsA-3002) [internet]. Report No.: nCT06671496. Available from clinicaltrials.gov; 2025 [cited 2025 Sep 22]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06671496"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2020.03.962"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.42519"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.06.426"},{"key":"e_1_3_5_75_1","unstructured":"Janssen Research & Development LLC. A phase 3 multicenter randomized double-blind placebo-controlled study evaluating the efficacy and safety of JNJ-77242113 for the treatment of biologic-na\u00efve participants with active psoriatic arthritis [internet]. Report No.: nCT06878404. Available from clinicaltrials.gov; 2025 [cited 2025 Sep 22]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06878404"},{"key":"e_1_3_5_76_1","unstructured":"Janssen Research & Development LLC. A phase 3 multicenter randomized double-blind placebo-controlled study evaluating the efficacy and safety of JNJ-77242113 for the treatment of biologic-experienced participants with active psoriatic arthritis [internet]. Report No.: nCT06807424. Available from clinicaltrials.gov; 2025 [cited 2025 Sep 22]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06807424"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.35"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2010.04.014"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1080\/19420862.2023.2209920"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljad186"},{"issue":"25","key":"e_1_3_5_81_1","first-page":"00815","article-title":"Efficacy and safety of izokibep in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study","volume":"0003","author":"Taylor PC","year":"2025","unstructured":"Taylor PC, Mease PJ, de Vlam K, et al. Efficacy and safety of izokibep in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study. Ann Rheum Dis. 2025;S0003-4967(25):00815\u20135.","journal-title":"Ann Rheum Dis"},{"key":"e_1_3_5_82_1","unstructured":"Acelyrin Inc. Acelyrin announces pipeline reprioritization and provides corporate update [internet]. U.S. Securities and Exchange Commission; 2024 [cited 2025 Sep 27]. Available from: https:\/\/www.sec.gov\/Archives\/edgar\/data\/1962918\/000196291824000104\/slrn-8kx8132024xexx991.htm?utm"},{"key":"e_1_3_5_83_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02900-y"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-021-00332-6"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065994"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00440-2"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03971-6"},{"key":"e_1_3_5_88_1","doi-asserted-by":"publisher","DOI":"10.1093\/rap\/rkaa070"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-025-03518-7"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-023-00574-w"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.31138\/mjr.2506241.dtt"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2025.2605204"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.05.112"},{"key":"e_1_3_5_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103865"},{"key":"e_1_3_5_95_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1283251"},{"key":"e_1_3_5_96_1","unstructured":"Janssen Research & Development LLC. A phase 2a multicenter randomized double-blind study evaluating the efficacy and safety of subcutaneously administered Guselkumab and golimumab combination therapy in participants with active psoriatic arthritis [Internet]. Report No.: nCT05071664. Available from clinicaltrials.gov; 2025 [cited 2025 Dec 26]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05071664"},{"key":"e_1_3_5_97_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12735"},{"key":"e_1_3_5_98_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1810-5"},{"key":"e_1_3_5_99_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-013-3145-0"},{"key":"e_1_3_5_100_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-012-2592-3"},{"key":"e_1_3_5_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2018.03.001"},{"key":"e_1_3_5_102_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1446468"},{"key":"e_1_3_5_103_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2011.12.039"},{"key":"e_1_3_5_104_1","doi-asserted-by":"publisher","DOI":"10.2337\/db09-1694"},{"key":"e_1_3_5_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2018.09.004"},{"key":"e_1_3_5_106_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2012.04609.x"},{"key":"e_1_3_5_107_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2023.05.021"},{"key":"e_1_3_5_108_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.03.002"},{"key":"e_1_3_5_109_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-011-2232-3"},{"key":"e_1_3_5_110_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.reuma.2024.501809"},{"key":"e_1_3_5_111_1","unstructured":"Glucagon-like peptide-1 receptor agonists therapy is associated in improvement in psoriatic arthritis-related and metabolic outcomes: a retrospective analysis of two cohorts [internet]. ACR Meeting Abstracts; [cited 2025 Dec 27]. Available from: https:\/\/acrabstracts.org\/abstract\/glucagon-like-peptide-1-receptor-agonists-therapy-is-associated-in-improvement-in-psoriatic-arthritis-related-and-metabolic-outcomes-a-retrospective-analysis-of-two-cohorts\/"},{"key":"e_1_3_5_112_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.70134"},{"key":"e_1_3_5_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2025.12.035"},{"key":"e_1_3_5_114_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003809"},{"key":"e_1_3_5_115_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-025-01329-3"},{"key":"e_1_3_5_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2025.10.002"},{"key":"e_1_3_5_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2012.09.004"},{"key":"e_1_3_5_118_1","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X251325665"},{"key":"e_1_3_5_119_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-75190-x"},{"key":"e_1_3_5_120_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-025-02140-2"},{"key":"e_1_3_5_121_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.25112"},{"key":"e_1_3_5_122_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2022-002681"},{"key":"e_1_3_5_123_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06218-8"},{"key":"e_1_3_5_124_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000181"},{"key":"e_1_3_5_125_1","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2021\/e3015"},{"key":"e_1_3_5_126_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-021-00420-x"},{"key":"e_1_3_5_127_1","volume-title":"Genetic determinants of psoriatic arthritis","author":"Chandran V","year":"2014","unstructured":"Chandran V. Genetic determinants of psoriatic arthritis. Toronto, ON, Canada: University of Toronto; 2014."},{"key":"e_1_3_5_128_1","doi-asserted-by":"publisher","DOI":"10.4081\/reumatismo.2007.1s.52"},{"key":"e_1_3_5_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2026.02.011"},{"issue":"25","key":"e_1_3_5_130_1","first-page":"04450","article-title":"CD3+ immune cell endotypes are associated with PsA disease phenotype and response to advanced therapy: an integrated mass cytometry and proteomics cohort study","volume":"0003","author":"Eder L","year":"2025","unstructured":"Eder L, Dang S, Caucheteux SM, et al. CD3+ immune cell endotypes are associated with PsA disease phenotype and response to advanced therapy: an integrated mass cytometry and proteomics cohort study. Ann Rheum Dis. 2025;S0003-4967(25):04450\u20134.","journal-title":"Ann Rheum Dis"},{"key":"e_1_3_5_131_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf311"},{"key":"e_1_3_5_132_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12040815"},{"key":"e_1_3_5_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2012.11.005"},{"key":"e_1_3_5_134_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140223"},{"key":"e_1_3_5_135_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae399"},{"key":"e_1_3_5_136_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103839"},{"key":"e_1_3_5_137_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-225443"},{"key":"e_1_3_5_138_1","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X241288060"},{"key":"e_1_3_5_139_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac078"},{"key":"e_1_3_5_140_1","doi-asserted-by":"publisher","DOI":"10.2196\/55855"},{"key":"e_1_3_5_141_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.917939"},{"key":"e_1_3_5_142_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-025-03660-2"},{"key":"e_1_3_5_143_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2025.152639"},{"key":"e_1_3_5_144_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq091"}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2026.2667340","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T05:48:15Z","timestamp":1778824095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2026.2667340"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,3]]},"references-count":142,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,4]]}},"alternative-id":["10.1080\/17512433.2026.2667340"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2026.2667340","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"value":"1751-2433","type":"print"},{"value":"1751-2441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-02-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}